Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Cardiff Oncology Inc. buy DrMabuse

Start price
€7.40
19.09.20 / 50%
Target price
-
29.09.20
Performance (%)
72.97%
End price
€12.80
29.09.20
Summary
This prediction ended on 29.09.20 with a price of €12.80. The BUY prediction by DrMabuse for Cardiff Oncology Inc. saw massive gains of 72.97%. DrMabuse has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y 3y
Cardiff Oncology Inc. 4.339% 4.339% 261.968% -41.657%
iShares Core DAX® 1.883% 5.122% 21.667% 22.437%
iShares Nasdaq 100 0.125% 2.574% 45.951% 55.507%
iShares Nikkei 225® -0.201% 4.341% 28.806% 9.945%
iShares S&P 500 0.728% 4.141% 34.630% 50.086%

According to DrMabuse what are the pros and cons of Cardiff Oncology Inc. for the foreseeable future?

Pros
Cons
High risks for its business

Comments by DrMabuse for this prediction

In the thread Trovagene diskutieren

Buy Cardiff Oncology Inc.

In the thread Trading Trovagene
Prediction Buy
Perf. (%) 72.97%
Target price
Change
Ends at 29.09.20

Buy beendet

Stopped prediction by DrMabuse for Cardiff Oncology Inc.

Cardiff Oncology Inc.

Start price
Target price
Perf. (%)
€4.94
06.09.20
-
19.09.20
49.80%
19.09.20

High risks for its business
Cardiff Oncology Inc.

Start price
Target price
Perf. (%)
€4.93
03.09.20
-
03.09.20
-
03.09.20

High risks for its business
buy
Cardiff Oncology Inc.

Start price
Target price
Perf. (%)
€6.65
22.08.20
-
03.09.20
-11.28%
03.09.20

High risks for its business
buy
Cardiff Oncology Inc.

Start price
Target price
Perf. (%)
€5.40
08.08.20
-
21.08.20
23.15%
21.08.20

High risks for its business
Cardiff Oncology Inc.

Start price
Target price
Perf. (%)
€3.80
25.07.20
-
08.08.20
42.11%
08.08.20

High risks for its business
buy
Cardiff Oncology Inc.

Start price
Target price
Perf. (%)
€2.06
14.06.20
-
27.06.20
111.65%
27.06.20

High risks for its business